https://thewitfire.in/iqvia-signal-wegovy-pill-may-expand-the-glp-1-market-not-just-replace-injections/Witfire Elite Pharma Newsen2026-06-06T07:50:53+00:00IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections https://thewitfire.in/fda-digital-liver-break-how-ai-toxicology-could-change-drug-development-before-phase-i/Witfire Elite Pharma Newsen2026-06-06T07:10:29+00:00FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I https://thewitfire.in/china-biotech-pipeline-grab-big-pharma-licensing-case-study/Witfire Elite Pharma Newsen2026-06-05T15:54:45+00:00The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China https://thewitfire.in/the-pharma-tariff-war-how-us-drug-pricing-pressure-is-forcing-big-pharma-to-rewrite-global-strategy/Witfire Elite Pharma Newsen2026-06-05T15:16:34+00:00The Pharma Tariff War: How US Drug Pricing Pressure Is Forcing Big Pharma to Rewrite Global Strategy https://thewitfire.in/how-glp-1-became-pharmas-most-powerful-growth-story/Witfire Elite Pharma Newsen2026-06-05T09:55:28+00:00How GLP-1 Became Pharma’s Most Powerful Growth Story https://thewitfire.in/glp-1-market-becomes-pharmas-biggest-business-battle/Witfire Elite Pharma Newsen2026-06-05T08:36:50+00:00GLP-1 Market Becomes Pharma’s Biggest Business Battle https://thewitfire.in/war-heat-reaches-pharma-as-oil-air-cargo-and-cold-chain-drugs-face-pressure/Witfire Elite Pharma Newsen2026-06-05T08:18:32+00:00War Heat Reaches Pharma as Oil, Air Cargo and Cold-Chain Drugs Face Pressure